TABLE 2.
Topic | Reference | Year published |
---|---|---|
General HDR brachytherapy QA/QC/QM programs | AAPM report 41 15 | 1993 |
AAPM report 46 16 | 1994 | |
AAPM report 59 17 | 1997 | |
AAPM report 61 18 | 1998 | |
ASTRO/PRO special article 19 | 2014 | |
IAEA 2D to 3D 20 | 2015 | |
COMP/CPQR quality guidelines 21 | 2018 | |
NCS code of practice 22 | 2018 | |
ACR/ABS/ASTRO practice parameter 23 | 2020 | |
ACR/AAPM technical standard 24 | 2020 | |
Dosimetric formalisms and consensus data | AAPM and ESTRO report 229 25 | 2012 |
Uncertainties in brachytherapy | AAPM/GEC‐ESTRO report 138 26 | 2011 |
GEC‐ESTRO/AAPM review 27 | 2014 | |
Treatment planning | AAPM report 62 28 | 1998 |
CPQR quality guidelines 29 | 2018 | |
Model‐based dose calculation | AAPM report 186 30 | 2012 |
Surface brachytherapy | AAPM/GEC ESTRO report 253 31 | 2020 |
Safety and risk analysis methodology | ICRP prevention of accidents 32 | 2005 |
AAPM report 283 33 | 2016 | |
ASTRO safety is no accident 34 | 2012 and 2019 |
Abbreviations: AAPM, American Association of Physicists in Medicine; ABS, American Brachytherapy Society; ACR, American College of Radiology; ASTRO, American Society for Therapeutic Radiation Oncology; COMP, Canadian Organization of Medical Physicists; CPQR, Canadian Partnership for Quality Radiotherapy; ESTRO, European Society for Therapeutic Radiology and Oncology; GEC, The Groupe Européen de Curiethérapie; HDR, high‐dose rate brachytherapy; ICRP, International Commission on Radiological Protection; NCS, Nederlandse Commissie voor Stralingsdosimetrie; QA, quality assurance; QC, quality control; QM, quality management.